TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33172506

Group type: EXPERIMENTAL
Intervention: OMNI (animal-derived protein diet; n=9; 1.8 g/kg body mass per day)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: VEG (vegan protein diet; n=10; mycoprotein providing 57% of daily protein intake; 1.8 g/kg body mass per day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparison of OMNI and VEG
Number of subjects: 19
Study: 34773261

Group type: EXPERIMENTAL
Intervention: ligelizumab 240 mg
Number of subjects: 237
Study: 32439253

Group type: EXPERIMENTAL
Intervention: TelePR programme (3 weekly training sessions, performance data sent through an app)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: TelePR programme
Number of subjects: 94

Group type: COMPARATOR
Intervention: Usual care (advised to exercise regularly)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 94
Study: 32161055

Group type: EXPERIMENTAL
Intervention: Initial combination therapy with ambrisentan plus tadalafil (COMB)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Monotherapy of either ambrisentan or tadalafil (MONO)
Number of subjects: 216
Study: 36117457

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 24
Study: 33080017

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ), 8 mg/kg intravenously plus usual care on day 1 and on day 3 if clinically indicated.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ), 8 mg/kg intravenously plus usual care.
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care (UC) alone.
Number of subjects: 130
Study: 32150048

Group type: COMPARATOR
Intervention: Placebo (SHAM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PBMT with red laser (660 nm, 0.034 cm, 88 J/cm, 100 mW, 3 J/point)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PBMT with infrared laser (808 nm, 0.034 cm, 88 J/cm, 100 mW, 3 J/point)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PBMT with red and infrared laser alternated between sessions
Number of subjects: 100
Study: 32578037

Group type: EXPERIMENTAL
Intervention: Mindfulness-based interventions (MBIs)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Educational interventions (EIs)
Number of subjects: 138
Study: 33829844

Group type: EXPERIMENTAL
Intervention: Linking methods by Choi et al. (2014)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linking in internal data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imputation using bridge study data from external data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imputation using bridge study data from internal data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imputation methods with patient demographics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Linking methods
Number of subjects: 0
Study: 35257993

Group type: EXPERIMENTAL
Intervention: Qigong/Tai Chi
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Latin dance
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 20
Study: 33004682

Group type: EXPERIMENTAL
Intervention: Unloaded sprint training (G0%)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Resisted sprint training (G40%)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (G0% and G40%)
Number of subjects: 28
Study: 34043677

Group type: EXPERIMENTAL
Intervention: High-frequency image-guided radiotherapy (hfIGRT)
Number of subjects: 4430

Group type: COMPARATOR
Intervention: No hfIGRT (Control)
Number of subjects: 4430
Study: 36123717

Group type: EXPERIMENTAL
Intervention: Music therapy with patient’s musical preference at 60 dB
Number of subjects: 68

Group type: COMPARATOR
Intervention: Headphones without any musical transmission (Control)
Number of subjects: 68
Study: 33436462

Group type: EXPERIMENTAL
Intervention: Carer Support Needs Assessment Tool for Stroke (CSNAT‐Stroke) intervention
Number of subjects: 21
Study: 34866340

Group type: EXPERIMENTAL
Intervention: Microdiscectomy at 6 weeks from onset of symptoms
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Microdiscectomy at 3 months from onset of symptoms
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Microdiscectomy at 6 months from onset of symptoms
Number of subjects: 122
Study: 33516014

Group type: EXPERIMENTAL
Intervention: Dried citrus pulp (DCP) at 150 g/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Grape pomace (DGP) at 150 g/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control diet (CON)
Number of subjects: 24
Study: 34106648

Group type: EXPERIMENTAL
Intervention: 45° prone position ventilation (PPV) for 7 days
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: 45° prone position ventilation (PPV)
Number of subjects: 268
Study: 34812127

Group type: EXPERIMENTAL
Intervention: Alive A. muciniphila
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pasteurized A. muciniphila
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33208739

Group type: EXPERIMENTAL
Intervention: Household level
Number of subjects: 1082100

Group type: EXPERIMENTAL
Intervention: Community level
Number of subjects: 1082100

Group type: EXPERIMENTAL
Intervention: District level
Number of subjects: 1082100

Group type: EXPERIMENTAL
Intervention: State level
Number of subjects: 1082100

Group type: EXPERIMENTAL
Intervention: Economically developed districts
Number of subjects: 1082100
Study: 35781191

Group type: COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Number of subjects: 27
Study: 33927126

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation for 1 year
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 34472200

Group type: EXPERIMENTAL
Intervention: 5‐mg flunarizine hydrochloride capsules (test)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 5‐mg flunarizine hydrochloride capsules (test) with high-fat meals
Number of subjects: 63

Group type: COMPARATOR
Intervention: 5‐mg flunarizine hydrochloride capsules (reference)
Number of subjects: 63
Study: 32571381

Group type: EXPERIMENTAL
Intervention: Monitoring visits by local NAPPMED
Number of subjects: 160

Group type: COMPARATOR
Intervention: Regulatory agencies
Number of subjects: 160
Study: 36097005

Group type: EXPERIMENTAL
Intervention: Urate-lowering therapies (ULT) - allopurinol and febuxostat, treated during at least 75% of the study period (PT ≥ 75; n=51)
Number of subjects: 1673

Group type: EXPERIMENTAL
Intervention: Urate-lowering therapies (ULT) - treated less than 75% of the study period (PT < 75; n=31)
Number of subjects: 1673

Group type: COMPARATOR
Intervention: Non-treated participants (PNT; n=1591)
Number of subjects: 1673
Study: 33743283

Group type: EXPERIMENTAL
Intervention: Tryptophan-enriched diet
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study: 32058675

Group type: EXPERIMENTAL
Intervention: Active air purifier
Number of subjects: 90

Group type: COMPARATOR
Intervention: Inactive air purifier
Number of subjects: 90
Study: 36500997

Group type: EXPERIMENTAL
Intervention: Padres program (intervention)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Delayed-treatment control group
Number of subjects: 94
Study: 32930845

Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy (PCNL) in patients with SCI
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (patients with complete staghorn calculus, GSS=4)
Number of subjects: 117
Study: 32084445

Group type: EXPERIMENTAL
Intervention: Educational interventions targeting leadership, clinicians, and patients, followed by behavioral economics-informed clinician feedback on statin uptake.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral economics-informed clinician feedback on statin uptake.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational interventions targeting leadership, clinicians, and patients.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation of educational interventions and clinician feedback.
Number of subjects: 0
Study: 36191982

Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 25(OH)D3
Number of subjects: 6
Study: 33583034

Group type: EXPERIMENTAL
Intervention: Higher dose of dexamethasone (12 mg)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Lower dose of dexamethasone (6 mg)
Number of subjects: 1000
Study: 35899336

Group type: COMPARATOR
Intervention: General anesthesia+lidocaine
Number of subjects: 169

Group type: COMPARATOR
Intervention: General anesthesia+ibuprofen suppository
Number of subjects: 169

Group type: COMPARATOR
Intervention: Three-drug combination (general anesthesia + lidocaine + ibuprofen suppository)
Number of subjects: 169

Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 169
Study: 32565008

Group type: EXPERIMENTAL
Intervention: 20 mg/day methylphenidate
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: DCA
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: NPI-apathy
Number of subjects: 180
Study: 32498871

Group type: EXPERIMENTAL
Intervention: Randomised SIMPLISMA algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Principal Component Analysis (PCA)
Number of subjects: 0
Study: 35047059

Group type: EXPERIMENTAL
Intervention: Autoimmune cell therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study: 36137626

Group type: EXPERIMENTAL
Intervention: Home-based Radio-Taiso exercise and nutrition programme
Number of subjects: 226

Group type: COMPARATOR
Intervention: Nutrition programme
Number of subjects: 226
Study: 33158705

Group type: EXPERIMENTAL
Intervention: Smart-Class group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Traditional group
Number of subjects: 57
Study: 34535162

Group type: EXPERIMENTAL
Intervention: DISCO App (intervention arm 2 and arm 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DISCO App with intervention booster (intervention arm 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control arm 1)
Number of subjects: 0
Study: 32487184

Group type: EXPERIMENTAL
Intervention: Intraoperative electron radiotherapy (IOERT) - 21 Gy to the 90% isodose during breast conserving surgery (BCS)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard hypofractionated whole-breast radiotherapy (WBI) - 40.05 Gy, 15 fractions after surgical resection
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Intraoperative electron radiotherapy (IOERT)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard hypofractionated whole-breast radiotherapy (WBI)
Number of subjects: 202
Study: 35965423

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT) guided by a hemodynamic monitoring system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard fluid therapy based on mean arterial pressure and diuresis
Number of subjects: 60
Study: 34028009

Group type: EXPERIMENTAL
Intervention: Situation awareness model consisting of regional early warning score, skin observation, clinical concern, patients’ and relatives’ concerns, pain, dyspnea, and team risk assessment.
Number of subjects: 21839

Group type: COMPARATOR
Intervention: Conventional early warning score system (control group).
Number of subjects: 21839
Study: 35677096

Group type: EXPERIMENTAL
Intervention: Routine drugs combined with cardiac rehabilitation for 6 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine drug therapy
Number of subjects: 100
Study: 36606020

Group type: EXPERIMENTAL
Intervention: Buspirone 5mg three times a day for the first month and 10mg three times a day for the second month (n=18)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (n=12)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (Buspirone and Placebo)
Number of subjects: 30
Study: 35725294

Group type: EXPERIMENTAL
Intervention: Placebo + continued MTX
Number of subjects: 398

Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 398
Study: 32163637

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein cholesterol (LDL-C)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Estimated BMD (eBMD)
Number of subjects: 400
Study: 35659704

Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg (ipi3)
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg (ipi10)
Number of subjects: 718

Group type: COMPARATOR
Intervention: High-dose IFNα (HDI)
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Peripheral blood analysis
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Tumor gene expression profiling (GEP)
Number of subjects: 718
Study: 33854983

Group type: EXPERIMENTAL
Intervention: Supplemented formula with prebiotics and OPO
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 108
Study: 32875756

Group type: EXPERIMENTAL
Intervention: TightRope group
Number of subjects: 128

Group type: COMPARATOR
Intervention: Double Endobutton group
Number of subjects: 128

Group type: COMPARATOR
Intervention: Triple-Endobutton group
Number of subjects: 128
Study: 35349415

Group type: EXPERIMENTAL
Intervention: Pegloticase biweekly (responders, n=36)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (n=43)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Pegloticase biweekly (responders, n=27 with Fib-4 >1.3)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (n=27 with Fib-4 >1.3)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Serum urate area under the curve (AUC)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Serum urate AUC
Number of subjects: 79
Study: 34391270

Group type: EXPERIMENTAL
Intervention: Sling-based manual therapy applied to the cervicothoracic junction (C7-T3) and upper cervical spine (C0-C1).
Number of subjects: 22

Group type: COMPARATOR
Intervention: Joint mobilization and motor control training for the upper cervical spine (C0-C1) in the control group.
Number of subjects: 22
Study: 32830108

Group type: EXPERIMENTAL
Intervention: Access to primary care records in the emergency department
Number of subjects: 8184

Group type: COMPARATOR
Intervention: Control group (17,449 randomly selected index presentations)
Number of subjects: 8184
Study: 35622108

Group type: EXPERIMENTAL
Intervention: Low-load volitional failure (LVoF) - 3 sets to failure at 40% one repetition maximum (1RM)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-load velocity fatigue (LVeF) - 3 sets to velocity fatigue at 40% 1RM
Number of subjects: 27

Group type: COMPARATOR
Intervention: High-load (HL) - 3 sets of 8 repetitions at 80% 1RM
Number of subjects: 27
Study: 34521374

Group type: EXPERIMENTAL
Intervention: Insecticide-treated wall liner (ITWL)
Number of subjects: 5666

Group type: COMPARATOR
Intervention: Indoor residual spraying (IRS)
Number of subjects: 5666
Study: 36301617

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34399060

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 137870

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 137870

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 137870

Group type: EXPERIMENTAL
Intervention: Remdesivir and Dexamethasone
Number of subjects: 137870
Study: 32487236

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg) administered 3 times/week for 3 or 4 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Ketamine maintenance (weekly infusions for 1 month, then bi-weekly for 2 months, and finally monthly for 3 months)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard of care ECT maintenance
Number of subjects: 240
Study: 35446236

Group type: EXPERIMENTAL
Intervention: Current NSSI (n=402)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Lifetime NSSI (n=88)
Number of subjects: 490
Study: 32102506

Group type: EXPERIMENTAL
Intervention: ACEI (Captopril)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35931989

Group type: EXPERIMENTAL
Intervention: 30 μg dexmedetomidine as a perineural adjuvant
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (20 mL 0.5% ropivacaine without dexmedetomidine)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 30 μg dexmedetomidine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study: 32234601

Group type: EXPERIMENTAL
Intervention: NMDAR ab(+)/MOG ab(+) group
Number of subjects: 7

Group type: COMPARATOR
Intervention: NMDAR ab(+)/MOG ab(−) group
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Relapsed patients
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Patients with neurological sequelae
Number of subjects: 7
Study: 33176381

Group type: EXPERIMENTAL
Intervention: Video game group (Xbox Kinect game for 60 min, 3 sessions/week)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Aquatic exercise group (aerobic exercise, 3 times/week)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study: 36476079

Group type: EXPERIMENTAL
Intervention: Re-reading a favorite novel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading a new novel of interest
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading a set of newspaper articles
Number of subjects: 0
Study: 34808751

Group type: EXPERIMENTAL
Intervention: Bulleyaconitine A tablets combined with gabapentin
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo combined with gabapentin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Bulleyaconitine A tablets
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups (Bulleyaconitine A + gabapentin and placebo + gabapentin)
Number of subjects: 75
Study: 32276179

Group type: EXPERIMENTAL
Intervention: Paclitaxel (90 mg/m2 on days 1, 8, 15) plus Bevacizumab (10 mg/kg on days 1, 15) every 28 days
Number of subjects: 166

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2) every 21 days
Number of subjects: 166
Study: 33810921

Group type: EXPERIMENTAL
Intervention: Shockwave Lithotripsy (SWL)
Number of subjects: 613

Group type: COMPARATOR
Intervention: Ureteroscopy (URS)
Number of subjects: 613
Study: 33148066

Group type: EXPERIMENTAL
Intervention: Community Health Worker delivered home-based Wee Wheezers asthma education program
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 151
Study: 34494931

Group type: EXPERIMENTAL
Intervention: Extended TIP (e‐TIP)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard TIP (s‐TIP)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Urethral plate width and e‐TIP technique
Number of subjects: 94
Study: 35397544

Group type: EXPERIMENTAL
Intervention: HCV self-testing distributed via study staff
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Information pamphlets encouraging individuals to visit a testing facility for HCV screening (Control)
Number of subjects: 2000
Study: 34085614

Group type: EXPERIMENTAL
Intervention: Modified reporting of positive urine cultures
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard reporting of positive urine cultures
Number of subjects: 100
Study: 32585332

Group type: EXPERIMENTAL
Intervention: Intratumoral H2O2 + external beam RT (36 Gy in 6 fractions)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intratumoral H2O2 + external beam RT (49.5 Gy in 18 fractions)
Number of subjects: 12
Study: 35678206

Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vorinostat
Number of subjects: 0
Study: 35703041

Group type: EXPERIMENTAL
Intervention: Eluvia stent
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Zilver PTX stent
Number of subjects: 10000
Study: 35905792

Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Health Education and Wellness (HEW)
Number of subjects: 40
Study: 34526101

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided paramedian approach
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ultrasound-guided median approach
Number of subjects: 100
Study: 32711396

Group type: EXPERIMENTAL
Intervention: Peer encouragement
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no peer encouragement)
Number of subjects: 84
Study: 35093535

Group type: EXPERIMENTAL
Intervention: Intravenous triiodothyronine (T3) supplementation
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 33739980

Group type: EXPERIMENTAL
Intervention: Hyperglycaemic clamp
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo clamp
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 1-back and 2-back tests during clamp procedures
Number of subjects: 70

Group type: COMPARATOR
Intervention: fMRI during placebo clamp
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: fMRI during hyperglycaemia
Number of subjects: 70
Study: 32325038

Group type: EXPERIMENTAL
Intervention: ChAdOx1 MERS (5×10^9 viral particles)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ChAdOx1 MERS (2.5×10^10 viral particles)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ChAdOx1 MERS (5×10^10 viral particles)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ChAdOx1 MERS (all doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ChAdOx1 MERS (high-dose)
Number of subjects: 24
Study: 36315433

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 15
Study: 33871596

Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg every 2 weeks plus conventional synthetic DMARDs
Number of subjects: 546
Study: 36472197

Group type: EXPERIMENTAL
Intervention: Bromocriptine (BCQR)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 35729630

Group type: EXPERIMENTAL
Intervention: Intervention condition (state-tailored data about rates of ACEs and economic evidence)
Number of subjects: 6509

Group type: COMPARATOR
Intervention: Enhanced control condition (state-tailored data without economic evidence)
Number of subjects: 6509

Group type: COMPARATOR
Intervention: Control condition (national data without economic evidence)
Number of subjects: 6509

Group type: EXPERIMENTAL
Intervention: Intervention condition
Number of subjects: 6509